Brief: Genprex Granted Chinese Patent For REQORSA Immunogene Therapy In Combination With PD-1 Antibodies To Treat Cancers
05/07/2023 13:36
July 5 (Reuters) - Genprex Inc GNPX.O :
* GENPREX GRANTED CHINESE PATENT FOR REQORSA® IMMUNOGENE
THERAPY
IN COMBINATION WITH PD-1 ANTIBODIES TO TREAT CANCERS
* GENPREX INC - BROAD PATENT COVERS USE OF CO'S LEAD DRUG
CANDIDATE, REQORSA IMMUNOGENE THERAPY, IN COMBINATION WITH PD1
ANTIBODIES THROUGH 2037
Source text for Eikon: ID:nPn386TkGa
Further company coverage: GNPX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy